Document is current
Any future updates will be listed below
-
Authors
Sauler, Maor https://orcid.org/0000-0001-5240-7978
McDonough, John E.
Adams, Taylor S.
Kothapalli, Neeharika
Barnthaler, Thomas
Werder, Rhiannon B.
Schupp, Jonas C. https://orcid.org/0000-0002-7714-8076
Nouws, Jessica
Robertson, Matthew J.
Coarfa, Cristian https://orcid.org/0000-0002-4183-4939
Yang, Tao
Chioccioli, Maurizio
Omote, Norihito
Cosme, Carlos Jr
Poli, Sergio https://orcid.org/0000-0001-5442-3189
Ayaub, Ehab A.
Chu, Sarah G.
Jensen, Klaus H. https://orcid.org/0000-0003-3234-6068
Gomez, Jose L. https://orcid.org/0000-0002-6521-6318
Britto, Clemente J. https://orcid.org/0000-0002-1979-1151
Raredon, Micha Sam B. https://orcid.org/0000-0003-1441-6122
Niklason, Laura E.
Wilson, Andrew A.
Timshel, Pascal N.
Kaminski, Naftali https://orcid.org/0000-0001-5917-4601
Rosas, Ivan O.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08HL135402, R01HL155948)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Flight Attendant Medical Research Institute
Claude D. Pepper Older Americans Independence Center, Yale School of Medicine
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 14 December 2021
First Online: 25 January 2022
Competing interests
: N.K. reports personal fees from Biogen Idec, Boehringer Ingelheim, Third Rock, Samumed, Numedii, Astra Zeneca, Life Max, Tervnce, RohBar, and Pliant. Equity in Pliant. Collaboration with Miragen, Astra Zeneca. Grant from Veracyte, all outside the submitted work; In addition, N.K. has a patent New Therapies in Pulmonary Fibrosis, and a patent for Peripheral Blood Gene Expression licensed to Biotech. L.E.N. reports grants from Humacyte Inc., outside the submitted work. E.A.A. and S.G.C. report personal fees from Novartis Institutes of BioMedical Research, outside the submitted work. K.H.J. and P.N.T. are employed by Intomics. The remaining authors declare no competing interests.
